Mayeur C, Gratadoux JJ, Bridonneau C, Chegdani F, Larroque B, Kapel N, Corcos O, Thomas M, Joly F
Without clinical approval, clear safety data, or regulation, the risks far outweigh the short-term gains
Contributing factors include diabetes that has persisted for years, nerve damage following viral infections, medications that reduce stomach motility, connective tissue conditions, and changes from previous surgeries
Lo hizo tras considerar que el medicamento est respaldado por investigaciones cientficas de vanguardia y que se ha demostrado que es una herramienta fuerte para mejorar la salud de los que enfrentan desafos relacionados a la obesidad o tienen diabetes
Which experimental models generate this evidence, and what can each actually show